Risk Based Monitoring for GCP Compliance

This Webinar will help you how to ensure that your data and supporting documentation are in the appropriate format to comply with regulatory authority inspection. Risk based monitoring can contribute to better oversight and more efficient use of resources of clinical studies.

Purchase using Webinar All-Access Pass
One User Unlimited access to all recorded webinars for 6 Months

Recorded Version Only

(PPT + Recorded Streaming Link)

1x Person - Unlimited viewing for 6 Months (For multiple locations contact Customer Care)
rec Recorded Link and Ref. material will be available in My Account Section
Last Recorded Date: Mar-2019

Download File Only

(PPT + Recorded Training File)

Downloadable file is for usage in one location only.
(For multiple locations contact Customer Care)
Downloadable link along with the materials will be emailed within 2 business days
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Learning Objectives:
  • Understand the new requirements for risk based monitoring in clinical trials
  • Define the regulations and guidelines which cover risk based monitoring
  • Review of risk based monitoring approaches and methodology for clinical trial projects
  • Learn how to identify and evaluate risks for the investigator site and protocol for implementing risk based monitoring
  • Learn how to identify critical data
  • Evaluate the risk indicator and set thresholds
  • Consider how to implement this new concept within your organization
  • Hear best practice of these new risk requirements
Areas Covered in the Webinar:
  • Define risk based monitoring for clinical trials
  • Understand risk based monitoring tools and methodology used in clinical research projects
  • Explore the roles and responsibilities of those involved in risk based monitoring
  • How to plan risk based monitoring approaches for clinical trials
  • Understand how to identify and evaluate study site and protocol risks for targeted SDV
  • Develop and apply risk monitoring in your clinical trials
  • Learn how to document risk based monitoring in the monitoring plan
Who Will Benefit:

The session is relevant for professionals working in pharmaceutical, biotechnology, CRO, regulatory authorities and study sites including investigator initiated studies involved in clinical trials. It will also be of interest to those departments who liaise/support clinical trial personnel such as:

  • Clinical development managers and personnel
  • Clinical operations personnel
  • Clinical research associates
  • Clinical research archiving and document management personnel
  • Quality assurance managers and auditors
  • CROs using laboratories to analyze clinical trial samples
  • Project management
  • Sponsors and non-commercial sponsors
  • Consultants
  • Laboratories analyzing samples from clinical trials
  • Regulatory affairs personnel
  • Legal and regulatory authorities
Instructor Profile:
Laura Brown Laura Brown

Independent QA and Training Consultant, Laura Brown Training and Development

Dr Laura Brown is an independent Pharmaceutical QA, Management and Training Consultant, and Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. Laura has more than 20 years' experience of Quality Assurance and managing international clinical trials including risk identification and management and risk based monitoring. She has worked for several companies including GSK, Hoechst Marion Roussel, Good Clinical Research Practices and Phoenix International. She has consulted with numerous pharmaceutical companies, suppliers to the pharmaceutical industry as well as academic institutions.

Dr Brown has an MBA with specialization in project management including risk management. She is also the external project management expert for a pharmaceutical e-learning MSc module in project management covering risk management, and the author of two books on project management including the leading book “Pharmaceutical Project Management” (Gower).

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed